Conservative management is recommended as the preferred management option for most low-risk prostate cancer, with certain specific exceptions. Although many studies have documented significant heterogeneity in the utilization of conservative management among men with low-risk disease, less is known about the underlying reasons for this variation and whether the variation is due to differences in case mix with respect to the specific factors mentioned in the guidelines: age <55 years, African American race, and high-volume Gleason 6 disease. Our objective was to explore what proportion of the heterogeneity in the utilization of conservative management for low-risk prostate cancer could be explained by guideline-concordant factors.
INTRODUCTION AND OBJECTIVES:
Conservative management is recommended as the preferred management option for most low-risk prostate cancer, with certain specific exceptions. Although many studies have documented significant heterogeneity in the utilization of conservative management among men with low-risk disease, less is known about the underlying reasons for this variation and whether the variation is due to differences in case mix with respect to the specific factors mentioned in the guidelines: age <55 years, African American race, and high-volume Gleason 6 disease. Our objective was to explore what proportion of the heterogeneity in the utilization of conservative management for low-risk prostate cancer could be explained by guideline-concordant factors.
METHODS: We identified 15,667 men with low-risk prostate cancer in the VA healthcare system from 2010-2015 for whom data on biopsy cores was available. We examined the use of conservative management in the low-risk population, and within subgroups with a higher risk of progression as defined by the guidelines (age <55, black race, and >6% positive biopsy cores). Multivariable analysis was used to determine the contribution of guideline-concordant patient factors and other factors (e.g. hospital characteristics) with conservative management use in the low-risk population.
RESULTS: From 2010-2015, 64% of low-risk veterans underwent conservative management, which varied from 25% to 100% by VA facility. There were 1,187 (7.6%) men <55 years old, 4,161 (26.6%) black men and 769 (4.9%) men with >6 positive biopsy cores. Each of these groups received conservative management at significantly lower than average rates (47%, 60%, and 34%, respectively, p<0.001), as were men with more than one of these factors (46% conservative management for black men age <55; 25% for men age <55 with >6 positive cores; and 36% of for black men with >6 positive cores). However, the logistic regression model showed patient factors other than those enumerated in the guidelines (e.g. comorbidity) as well as non-patient factors (e.g., geography, urban vs. rural, case volume) were also significantly associated with conservative management use.
CONCLUSIONS: There remains significant heterogeneity in the uptake of conservative management for low-risk disease even within an integrated healthcare system. Only some of this heterogeneity could be explained by guideline-concordant patient factors, suggesting a complex decision-making process surrounding the selection of conservative management for low-risk prostate cancer patients. METHODS: The Michigan Urological Surgery Improvement Collaborative (MUSIC), a statewide quality improvement consortium of >250 diverse MI urologists, uses a web-based data registry to collect information regarding a patient's RP. In April 2014, MUSIC began a patient reported outcomes (PRO) program. RP patients completed validated surveys pre-and 3, 6, 12, and 24 months post-RP, and a goal was set to increase the social continence (0-1 pads per day) rate at 3-months post-RP. In this study, bivariate tests compared patient characteristics between lower and higher volume surgeons, and a mixed-effects logistic regression model determined the independent effect of volume on 3-month social continence.
RESULTS: The analysis included 2,704 patients treated by 108 RP surgeons (48 lower volume surgeons completing 202 RPs and 60 higher volume surgeons completing 2502 RPs). The social continence rate 3 months post-RP was 56% and 67% (p<0.001) for lower and higher volume surgeons, respectively. Lower volume surgeons were less likely to perform bilateral nerve sparing (46% vs 70%, p<0.001) and their patients had higher preoperative PSA (median 6.7 vs. 6.0, p[0.036). Other factors (BMI, race, clinical T stage, age) were not significantly different between volume groups. Higher volume surgeons' patients were more likely to reach social continence at 3 months post-RP (OR [1.81, p[0.006, Table) .
CONCLUSIONS: RP for localized PCa is a complex operation, and these data provide further evidence that all RP surgeons should participate in PRO. MUSIC PRO provides a framework to identify surgeon characteristics or techniques that may be useful in improving functional outcomes through activities such as skills workshops, video review, and mentoring.
Although the literature has shown clear disparities in prostate cancer incidence and mortality between Caucasian (Cau) and African American (AA) men, the specific factors that lead to adverse outcomes in AA men are less well characterized. We analyzed a regional prostate cancer collaborative to describe contemporary differences in disease-specific variables between Cau and AA men.
METHODS: We analyzed the Pennsylvania Urologic Regional Collaborative (PURC), a voluntary collaborative of urology practices in Pennsylvania and New Jersey. For men undergoing initial prostate biopsy, we compared biopsy outcomes between Cau and AA men. For men with a new diagnosis of prostate cancer, we compared clinicopathologic variables and management strategies by race.
RESULTS: Of 6,049 men who underwent prostate biopsy, 4618 (76.3%) were Cau and 1431 (23.7%) AA. AA men were younger at the time of biopsy, had higher PSA, and were more often diagnosed with prostate cancer and high-grade tumors (Table 1) .
Among 4034 men diagnosed with prostate cancer, 3,034 (75.2%) were Cau and 1,000 (24.8%) AA (Table 2) . AAs were younger at diagnosis, but were more likely to be diagnosed with metastatic disease. The distribution of Gleason grade group did not differ by race, but AA men had higher volume disease on biopsy. AA men were less likely to undergo radical prostatectomy (RP). Of men treated with RP, pathologic outcomes did not differ significantly by race, with the exception of surgical margins, which were more often positive in AA men.
CONCLUSIONS: AA men in the Philadelphia region are diagnosed with prostate cancer at a younger age, and more often have metastatic disease at diagnosis. For those with clinically localized disease, the primary difference between races was in disease volume, not tumor grade. Although AA men were less likely to undergo RP, those who were treated surgically had similar pathologic outcomes to Caucasians. This suggests that AA men with high-risk disease may preferentially undergo radiation as opposed to RP, which may have implications on long-term cancer specific survival.
